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Hypotension Aggravated by Dopamine in a Dog Under Isoflurane Anesthesia
Elizabeth Regina Carvalho1, Natache Arouca Garofalo2, Carolina Hagy Girotto2 & Francisco José Teixeira Neto2
ABSTRACT
Background: Hypotension (MAP < 60 mmHg) is the most common complication in anesthetic practice and has been 
identified in 38% of canine patients undergoing general anesthesia for variety of procedures. Normalization of arterial pres-
sure can usually be achieved by decreases in inhalant anesthetic concentrations, fluid administration, and use of inotropes/
vasopressors in healthy animals (ASA I) or animals with mild systemic disease (ASA anesthetic risk II). The present report 
shows an ASA II dog with severe hypotensive crisis [mean arterial pressure (MAP) < 50 mmHg] during general anesthesia, 
in which the procedure was aborted because hypotension was aggravated by dopamine.
Case: A 7-year-old male Bull Terrier was anesthetized for magnetic resonance imaging (MRI) of a tumor in the face. After 
intramuscular acepromazine (0.01 mg/kg) and meperidine (3 mg/kg), anesthesia was induced with intravenous (IV) ket-
amine (1 mg/kg) and propofol (2.3 mg/kg) and maintained with isoflurane in oxygen. Ten min after induction of anesthesia 
MAP was 45 mmHg, while end-tidal isoflurane (ETISO) concentration was 0.5%. End-tidal isoflurane was decreased to 
0.3% and an IV bolus of Lactated Ringer’s was initiated (15 mL/kg over 10 min), followed by two ephedrine boluses (0.1 
mg/kg, IV) administered 5 min apart. MAP remained low (< 50 mmHg) and dopamine constant rate infusion (CRI) was 
initiated (7.5 μg/kg/min). Ten minutes after dopamine CRI was commenced, MAP was further decreased to 25-22 mmHg. 
Dopamine CRI was increased to 10 μg/kg/min, but MAP remained < 25 mmHg. Infusion drugs and isoflurane anesthesia 
were stopped. After the animal was extubated MAP returned 60-70 mmHg.
Discussion: Among the drugs used, isoflurane is known for decreasing blood pressure in a dose-related manner because 
of its vasodilating properties. Hypotension is rarely associated with low end-tidal isoflurane concentrations (0.3-0.5%) 
in animals that do not present previous evidence of circulatory dysfunction. Acepromazine may have contributed to the 
hypotensive actions of isoflurane in the case reported here because of its vasodilating effects. Acepromazine has prolonged 
plasma half-life (7 h) and might also have contributed to the lack efficacy of ephedrine to treat hypotension. Aggravation of 
hypotension (MAP decreased from 45-50 mmHg to approximately 25 mmHg) by dopamine was unexpected. Aggravation 
of hypotension during administration of vasopressor doses of dopamine could be related to the activation of the cardiopul-
monary chemoreflex (CCR), previously known with the eponym Bezold-Jarisch reflex or due to a prevalence of dopamine´s 
vasodilatory effects (dopaminergic receptor stimulation) and failure of this drug in promiting increased CO and SVR at the 
dose ranges used (7.5 to 10 μg/kg/min).. The CCR involves activation of mechano and baroreceptors in the heart, by ino-
tropes such as dopamine and dobutamine. This activation originates vagal afferent impulses to the nucleus tractus solitarii 
of the spinal cord, which in turn originates parasympathetic afferent impulses to the heart. The consequence is an increase 
in parasympathetic outflow and decreased sympathetic activity, ultimately producing bradycardia, hypotension, or both.
Keywords: acepromazine, Bezold-Jarish reflex, cardiopulmonary chemoreflex, canine, inotropes.
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INTRODUCTION
Hypotension (MAP < 60 mmHg) is the most 
common complication in anesthetic practice and has 
been identified in 38% of canine patients undergo-
ing general anesthesia for variety of procedures [15]. 
However, this anesthetic-related complication is usu-
ally responsive to standard therapeutic measures which 
include decreases in inhalant anesthetic concentrations, 
fluid administration, and use of inotropes/vasopres-
sors in healthy animals (ASA I) or animals with mild 
systemic disease (ASA anesthetic risk II). The present 
report shows an ASA II dog with severe hypotensive 
crisis (MAP < 50 mmHg) during general anesthesia, 
in which the procedure was aborted because this com-
plication was aggravated by dopamine.
CASE
A 7-year-old male Bull Terrier with a previous 
history of squamous cell carcinoma was admitted at 
a Veterinary Teaching Hospital because of a nodule 
near the right third eyelid (Figure 1). This nodule was 
suspected as squamous cell carcinoma by fine needle 
aspiration cytology, and evidence of zygomatic arch 
bone lysis was present on radiographs. Magnetic reso-
nance imaging (MRI) and a computed tomography 
(CT) were indicated as part of surgical and radiotherapy 
planning. Two days before MRI and CT, blood samples 
were taken for CBC and biochemistry profile. The 
CBC showed leukopenia (5.400 ̸μL), due to lympho-
penia (300 μL), and thrombocytopenia (30.000 ̸μL). 
Hematocrit, total plasma protein and albumin values 
were 36%, 7.8 g/dL, and 2.5 g/dL respectively. The 
biochemistry profile showed that both liver and kidney 
function markers were within the reference values.
Food was withheld 12 h before anesthesia. 
Physical examination performed prior to anesthesia 
did not show remarkable changes. The dog’s behavior 
was docile but agitated, and acepromazine (0.01 mg/
kg) and meperidine (3 mg/kg) were given intramus-
cularly as premedication. A 20 Gauge catheter was 
placed in a cephalic vein, and anesthesia was induced 
with intravenous ketamine (1 mg/kg) followed by 
propofol titrated until orotracheal intubation was pos-
sible (2.3 mg/kg). Anesthesia was maintained with 
isoflurane in oxygen under spontaneous ventilation and 
the vaporizer settings were initially adjusted to 1.5% 
during instrumentation (placement of ECG electrodes, 
esophageal thermometer, pulse oximetry and anesthetic 
agent/carbon dioxide gas analyzer).
Immediately after orotracheal intubation, a 
dorsal pedal artery was catheterized with a 22 Gauge 
catheter and connected via a non-compliant tubing to 
a pressure transducer. The transducer was connected 
to the MRI compatible monitor (Medrad Veris 8600 
MRI Patient Monitoring Systems)1 zeroed at the heart 
level for monitoring systolic, diastolic, and mean arte-
rial pressures (SAP, DAP, and MAP). Oxygen satura-
tion was recorded by a pulse oxymeter (SpO2) with 
the MRI compatible probe connected to the prepuce; 
while end-tidal isoflurane concentrations (ETISO) and 
carbon dioxide (ETCO2) were monitored by an infrared 
anesthetic agent analyzer.
The MRI compatible ECG leads were attached 
to the thorax, with the right and left arm electrodes 
attached near the armpits and the left leg electrode 
attached as close as possible to the left leg and lead II 
configuration was selected for monitoring heart rate 
(HR) and rhythm with a MRI compatible monitor. 
Throughout anesthesia HR and SpO2 ranged from 96 to 
114 bpm and from 97 to 100%, respectively. Although 
the respiratory rate remained relatively low (6 to 10 
breaths/min), low ETCO2 values (20 to 25 mmHg) were 
recorded during anesthesia with a clearly identifiable 
expiratory plateau (phase III) in the capnogram.
Figure 1. Picture of the animal reported, a 7-year-old canine, male, Bull 
Terrier, commited by a suspected squamous cell carcinoma near to the 
third eyelid (arrow).
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The first arterial blood pressure reading was 
obtained approximately 5 min after induction. At 
that time, hypotension was recognized (MAP = 45 
mmHg), and a Lactated Ringer bolus (15 mL/kg, IV) 
was administered over 10 min. Although the ETISO was 
0.5% at that time, the dog did not show signs of light 
anesthesia (presence of palpebral reflexes and tachy-
pnea/respiratory efforts with increased amplitude). 
Therefore, the ETiso was decreased from 0.5 to 0.3% 
(oxygen flow rate = 1 L/min). Because MAP was still 
low (approximately 45 mmHg) after the fluid bolus 
was finished and the ETISO was decreased to 0.3%, an 
IV bolus of ephedrine (0.1 mg/kg) was given without a 
noticeable improvement in MAP. A second ephedrine 
bolus (same dose) was given 5 min later but MAP was 
still < 50 mmHg.
 A constant rate infusion (CRI) of dopamine 
was then initiated in an attempt to increase MAP to 
values > 60 mmHg. The dopamine CRI was set at 
7.5 μg/kg/min IV but MAP was further decreased to 
approximately 25 mmHg and the CRI was increased 
to 10 μg/kg/min, IV, approximately 10 min after the 
initial CRI was set. This dopamine CRI was maintained 
for another 10 min without any improvement in MAP. 
At that time, 20 min after starting dopamine CRI, ap-
proximately 40-45 min after induction of anesthesia, 
it was decided to discontinue dopamine and isoflurane 
administration and the MRI procedure was aborted. 
Less than 5 min after zeroing the vaporizer, the animal 
raised its head and the orotracheal tube was removed. A 
5 mL/kg, IV, bolus of 6% tetrastarch was administered 
over 5 min, and MAP increased to approximately 60 
to 70 mmHg during the immediate period after the 
orotracheal tube was removed. 
Chest radiographs, ECG and doppler echo-
cardiography were recommended before planning a 
second anesthetic procedure. Both radiographs and 
ECG did not show remarkable abnormalities. The 
echocardiographic evaluation showed marginally 
decreased fractional shortening [23%] (normal range 
for Bull Terriers: 24-41%) [13]. Other parameters were 
within reference values.
DISCUSSION
The present report showed an ASA II dog with 
severe hypotensive crisis (MAP < 50 mmHg) during 
general anesthesia in which the procedure was aborted 
because hypotension was aggravated by dopamine. 
Hypotension (MAP < 60 mmHg) is the most com-
mon complication in anesthetic practice and has been 
identified in 38% of canine patients undergoing general 
anesthesia for variety of procedures [15].  However, 
this anesthetic-related complication is usually respon-
sive to standard therapeutic measures which include 
decreases in inhalant anesthetic concentrations, fluid 
administration, and use of inotropes/vasopressors in 
healthy animals (ASA I) or animals with mild systemic 
disease (ASA anesthetic risk I to II).
Although the dog of the present case report had 
a squamous cell tumour in the face, its ASA anesthetic 
risk was rated as II (mild systemic disease) because this 
illness showed no significant systemic repercussions 
when the animal was presented for anesthesia (normal 
appetite and behavior, absence of evidence of metas-
tasis on X-ray evaluations, and biochemical markers 
of liver and kidney function within reference ranges).
Among the drugs used in the present case re-
port, isoflurane is known for decreasing blood pressure 
in a dose-related manner because of its vasodilating 
properties [17]. It is evident that the dog reported 
here was highly sensitive to the hypotensive actions 
of isoflurane. The ETISO recorded when severe hypo-
tension was first observed (0.5%) at 5-10 min after 
orotracheal intubation represented only 40% of the 
minimum alveolar concentration of isoflurane (MAC) 
alone (1.28%) [17]. In spite of the low ETISO at that 
time, the animal did not show signs of light anesthesia 
because the CNS depressing actions of isoflurane dur-
ing the early phase of anesthesia were potentiated by 
premedication and induction drugs and, for this reason 
the ETISO, was decreased to 0.3% but in an attempt to 
minimize hypotension.
Acepromazine is another drug that may have 
contributed to the hypotensive actions of isoflurane 
in the case reported here because it has also induces 
a vasodilatory effect [6]. Because acepromazine pre-
medication may result in prolonged clinical effects, 
which may be related to its prolonged plasma half-life 
(7 h) [7], this drug might also have contributed to the 
lack of efficacy of ephedrine to treat hypotension in the 
present case report [16]. The increase in blood pressure 
mediated by ephedrine is related to increases in cardiac 
output (CO)/myocardial contractility and to increases 
in systemic vascular resistance (SVR) [16,20]. The 
prolonged vasodilatory action of acepromazine might 
have contributed at least in part to the lack of efficacy 
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of ephedrine for treating hypotension, although the 
dose of acepromazine used as premedication (0.01 
mg/kg) was lower than the doses reported to interfere 
with the efficacy of vasopressor drugs (0.03 to 0.05 
mg/kg) [12,16].
Acepromazine is best avoided in animals that 
already present or are at risk of developing hypoten-
sion. However, we decided to use a low dose (0.01 mg/
kg) as a part of the premedication regime because the 
animal showed an agitated but docile behavior, and his 
clinical condition did not indicate that he was prone to 
hypotension during anesthesia.
The aggravation in the hypotensive crisis 
(MAP decreased from 45-50 mmHg to approximately 
25 mmHg) when dopamine was initiated to treat hy-
potension was unexpected. In isoflurane anesthetized 
dogs, dopamine CRIs ranging from 5 to 15 μg/kg/min 
significantly increased CO but MAP was increased only 
with the highest infusion rate [12]. When acepromazine 
was used as premedication (0.03 mg/kg), dopamine’s 
vasopressor effect recorded at 15 μg/kg/min, due to its 
increase in systemic vascular resistance with the high-
est dose, was partially blunted by the alfa-1 blocking 
properties of acepromazine.
Although acepromazine premedication may 
partially blunt dopamine’s vasopressor action and 
reduce its efficacy to treat hypotension, this action 
alone does not explain the aggravation of the hy-
potension recorded in the present case report after 
dopamine was initiated. Paradoxical aggravation of 
hypotension during administration of vasopressor 
doses of dopamine could be related to the activa-
tion of the cardiopulmonary chemoreflex (CCR), 
previously known with the eponym Bezold-Jarisch 
reflex [1] (Figure 2). The CCR involves activation 
of mechano and baroreceptors in the heart [1] by 
inotropes such as dopamine and dobutamine [1]. 
Such activation originates vagal afferent impulses to 
the nucleus tractus solitarius of the central nervous 
system, which in turn originates parasympathetic 
afferent impulses to the heart [19] and reflex vaso-
dilation [4]. The consequent increase in parasympa-
thetic outflow, associated decreases in sympathetic 
activity [19], ultimately produces bradycardia and/
or hypotension [14,18].
The CCR may has been reported in humans 
[14] and dogs [8,18]. In one case report, the use of do-
pamine to treat hypotension in 2 isoflurane anesthetized 
dogs was suspected to trigger the CCR [18]. Dopamine 
administration was associated with bradycardia (HR 
≤ 50 beats/min) in one animal at CRIs ranging from 7 
to 15 μg/kg/min, while in the second animal the bra-
dycardia observed during dopamine administration (7 
μg/kg/min) was also associated with an aggravation of 
hypotension (MAP = 40 mmHg) [18].
The paradoxical aggravation of hypotension 
during dopamine administration due to activation of 
the CCR reflex may be related to dopamine’s vaso-
dilatory effects (dopaminergic and beta adrenergic 
receptor stimulation) and an associated decrease in 
CO due to vagally mediated bradycardia. In CCR, 
the vasomotor inhibition occurs independently of 
cardiac modulation [2]. Therefore, bradycardia and 
hypotension could be isolated events [4].   In view of 
this mechanism, it could not be excluded that CCR 
activation may have caused the decrease of MAP after 
dopamine CRI in this dog.
Figure 2. Schematic representation of Bezold-Jarish reflex. [Source: Elizabeth Regina Carvalho].
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Dopamine acts as an agonist on alpha, beta-1, 
and beta-2 receptors, in addition to its agonistic effects 
on dopaminergic receptors [5]. The affinity for these 
receptors, and consequently the hemodynamic effects 
are dose-related [3,5]. Until now, there are no studies 
investigating the pharmacokinetics of dopamine in dogs, 
and infusion rates are based in recommendations for 
humans [5]. Therefore, these infusion rates cannot be 
extrapolated to animals as absolutely values, but as inter-
vals. At low infusion rates (1 to 3 μg/kg/min), as a general 
rule, dopaminergic effects prevails, leading to splanchnic 
and renal vasodilation, and inhibition of norepinephrine 
release [5]. At intermediate CRIs (5 to 8 μg/kg/min) do-
pamine has both beta-1 and alpha-1 adrenergic actions, 
and consequently positive inotropic effects with moderate 
vasoconstriction are seen [5]. At higher dopamine CRIs 
(8 to 20 μg/kg/min) the alpha adrenergic agonist action 
prevails, resulting peripheral vasoconstriction [3,5,10].
However, it has been reported in humans 
[11], that dopamine plasma concentration can present 
marked inter-individual variation in spite of a fixed 
infusion rate. The large variability in plasma levels may 
result in marked differences in hemodynamic effects 
for a fixed infusion rate of dopamine, because different 
plasma levels can impact receptor affinity. Although 
the CRI used in this case report generally results in 
positive inotropic effect (7.5 to 10 μg/kg/min), it is 
possible that specifically in this dog, those rates were 
not high enough to promote this effect. The low ET
co2 
(20-25 mmHg) with an identifiable expiratory plateau 
during anesthesia can be an evidence of low cardiac 
output [9] in this animal.
In conclusion, aggravation of the hypotensive 
crisis by dopamine in this case report could have been 
atribbuted to dopamine-induced vasodilation (dopami-
nergic effects) and to the failure of this drug in pro-
moting beta-1 and alfa-1 adrenergic effects at the dose 
ranges used (7.5 to 10 μg/kg/min). Another possible 
explanation is the activation of the Bezold-Jarish reflex.
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